Possible cyclosporin-danazol interaction in a patient with aplastic anaemia [4]

American Journal of Hematology

Volumn 62, Issue 1, 1999, Pages 63-64

  Borras Blasco, J ^a   Rosique Robles, J D ^a   Peris Marti, J ^a   Navarro Ruiz, J ^a   Gonzalez Delgado, M ^a   Conesa Garcia, V ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CYCLOSPORIN; DANAZOL; IMMUNOSUPPRESSIVE AGENT;

ADULT; APLASTIC ANEMIA; CASE REPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG MONITORING; HUMAN; HYPERTENSION; LETTER; LIVER TOXICITY; MALE; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANEMIA, APLASTIC; CYCLOSPORINE; CYTOCHROME P-450 ENZYME SYSTEM; DANAZOL; DRUG MONITORING; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METABOLIC DETOXICATION, DRUG;

EID: 0032866549     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199909)62:1<63::AID-AJH15>3.0.CO;2-R     Document Type: Letter

References (5)